![Xiao Kang Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao Kang Liu
Director/Miembro de la Junta en PharmaLegacy Laboratories (Shanghai) Co., Ltd. .
Perfil
Xiao Kang Liu is a graduate of Nanjing University.
Currently, he is a Member-Supervisory Board at PharmaLegacy Laboratories (Shanghai) Co., Ltd.
Cargos activos de Xiao Kang Liu
Empresas | Cargo | Inicio |
---|---|---|
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
![]() PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 01/04/2020 |
Formación de Xiao Kang Liu.
Nanjing University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
![]() PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
- Bolsa de valores
- Insiders
- Xiao Kang Liu